Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK Cell Infusion Combined With Chemotherapy in NSCLC
NCT02734524Phase 2Unknown
- Sponsor
- Southwest Health System
- Start
- Mar 2016
- Primary completion
- Mar 2018
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of troculeucel in non-small cell lung cancer (NSCLC), sponsored by Southwest Health System. Status: unknown.
02
Drugs
troculeucel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02734524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734524.